172 related articles for article (PubMed ID: 19607872)
1. EXAFS structural study of platinum-based anticancer drugs degradation in presence of sulfur nucleophilic species.
Provost K; Bouvet-Muller D; Crauste-Manciet S; Moscovici J; Olivi L; Vlaic G; Michalowicz A
Biochimie; 2009 Oct; 91(10):1301-6. PubMed ID: 19607872
[TBL] [Abstract][Full Text] [Related]
2. EXAFS and IR structural study of platinum-based anticancer drugs' degradation by diethyl dithiocarbamate.
Bouvet D; Michalowicz A; Crauste-Manciet S; Brossard D; Provost K
Inorg Chem; 2006 Apr; 45(8):3393-8. PubMed ID: 16602799
[TBL] [Abstract][Full Text] [Related]
3. EXAFS characterization of oxaliplatin anticancer drug and its degradation in chloride media.
Bouvet D; Michalowicz A; Crauste-Manciet S; Curis E; Nicolis I; Olivi L; Vlaic G; Brossard D; Provost K
J Synchrotron Radiat; 2006 Nov; 13(Pt 6):477-83. PubMed ID: 17057326
[TBL] [Abstract][Full Text] [Related]
4. Kinetic study on the reactions of platinum drugs with glutathione.
Hagrman D; Goodisman J; Souid AK
J Pharmacol Exp Ther; 2004 Feb; 308(2):658-66. PubMed ID: 14610218
[TBL] [Abstract][Full Text] [Related]
5. Differential nephrotoxicity of cisplatin and a novel series of traditional Chinese medicine-platinum anticancer agents correlates with their chemical reactivity towards sulfur-containing nucleophiles.
To KK; Au-Yeung SC; Ho YP
Anticancer Drugs; 2006 Jul; 17(6):673-83. PubMed ID: 16917213
[TBL] [Abstract][Full Text] [Related]
6. New platinum(II) complexes containing both an O,O'-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells.
Muscella A; Calabriso N; De Pascali SA; Urso L; Ciccarese A; Fanizzi FP; Migoni D; Marsigliante S
Biochem Pharmacol; 2007 Jun; 74(1):28-40. PubMed ID: 17481588
[TBL] [Abstract][Full Text] [Related]
7. Application of capillary electrophoresis-mass spectrometry for the investigation of the binding behavior of oxaliplatin to 5'-GMP in the presence of the sulfur-containing amino acid L-methionine.
Strickmann DB; Kong A; Keppler BK
Electrophoresis; 2002 Jan; 23(1):74-80. PubMed ID: 11824623
[TBL] [Abstract][Full Text] [Related]
8. Coupling CP-MD simulations and X-ray absorption spectroscopy: exploring the structure of oxaliplatin in aqueous solution.
Beret EC; Provost K; Müller D; Marcos ES
J Phys Chem B; 2009 Sep; 113(36):12343-52. PubMed ID: 19685899
[TBL] [Abstract][Full Text] [Related]
9. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
10. Characterization and cellular uptake of platinum anticancer drugs encapsulated in apoferritin.
Xing R; Wang X; Zhang C; Zhang Y; Wang Q; Yang Z; Guo Z
J Inorg Biochem; 2009 Jul; 103(7):1039-44. PubMed ID: 19501911
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the binding behavior of oxaliplatin, cisplatin and analogues to 5'-GMP in the presence of sulfur-containing molecules by means of capillary electrophoresis and electrospray mass spectrometry.
Küng A; Strickmann DB; Galanski MS; Keppler BK
J Inorg Biochem; 2001 Oct; 86(4):691-8. PubMed ID: 11583787
[TBL] [Abstract][Full Text] [Related]
12. Oxaliplatin degradation in the presence of important biological sulphur-containing compounds and plasma ultrafiltrate.
Jerremalm E; Wallin I; Yachnin J; Ehrsson H
Eur J Pharm Sci; 2006 Jul; 28(4):278-83. PubMed ID: 16621479
[TBL] [Abstract][Full Text] [Related]
13. Reaction of Zn7metallothionein with cis- and trans-[Pt(N-donor)2Cl2] anticancer complexes: trans-Pt(II) complexes retain their N-donor ligands.
Knipp M; Karotki AV; Chesnov S; Natile G; Sadler PJ; Brabec V; Vasák M
J Med Chem; 2007 Aug; 50(17):4075-86. PubMed ID: 17665893
[TBL] [Abstract][Full Text] [Related]
14. The kinetics and mechanisms of the reaction of Mesna with cisplatin, oxiplatin and carboplatin.
Oprea A; Bazzazi H; Kangarloo B; Wolff JE
Anticancer Res; 2001; 21(2A):1225-9. PubMed ID: 11396168
[TBL] [Abstract][Full Text] [Related]
15. Sensitive inductively coupled plasma mass spectrometry assay for the determination of platinum originating from cisplatin, carboplatin, and oxaliplatin in human plasma ultrafiltrate.
Brouwers EE; Tibben MM; Rosing H; Hillebrand MJ; Joerger M; Schellens JH; Beijnen JH
J Mass Spectrom; 2006 Sep; 41(9):1186-94. PubMed ID: 16929560
[TBL] [Abstract][Full Text] [Related]
16. Reactivity of kiteplatin with S-donor biomolecules and nucleotides.
Petruzzella E; Margiotta N; Natile G; Hoeschele JD
Dalton Trans; 2014 Sep; 43(34):12851-9. PubMed ID: 25051186
[TBL] [Abstract][Full Text] [Related]
17. Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance.
Lau JK; Deubel DV
Chemistry; 2005 Apr; 11(9):2849-55. PubMed ID: 15744707
[TBL] [Abstract][Full Text] [Related]
18. Carboplatin and oxaliplatin decomposition in chloride medium, monitored by XAS.
Curis E; Provost K; Bouvet D; Nicolis I; Crauste-Manciet S; Brossard D; Bénazeth S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):716-8. PubMed ID: 11512906
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
20. Characterization of platinum anticancer drug protein-binding sites using a top-down mass spectrometric approach.
Hartinger CG; Tsybin YO; Fuchser J; Dyson PJ
Inorg Chem; 2008 Jan; 47(1):17-9. PubMed ID: 18067289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
